159 related articles for article (PubMed ID: 27347165)
1. Effects of HCG on human epithelial ovarian cancer vasculogenic mimicry formation
Gao S; Fan C; Huang H; Zhu C; Su M; Zhang Y
Oncol Lett; 2016 Jul; 12(1):459-466. PubMed ID: 27347165
[TBL] [Abstract][Full Text] [Related]
2. Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian cancer cell line.
Su M; Wei W; Xu X; Wang X; Chen C; Su L; Zhang Y
Int J Gynecol Cancer; 2011 Nov; 21(8):1366-74. PubMed ID: 22027746
[TBL] [Abstract][Full Text] [Related]
3. Involvement of human chorionic gonadotropin in regulating vasculogenic mimicry and hypoxia-inducible factor-1α expression in ovarian cancer cells.
Su M; Xu X; Wei W; Gao S; Wang X; Chen C; Zhang Y
Cancer Cell Int; 2016; 16():50. PubMed ID: 27346985
[TBL] [Abstract][Full Text] [Related]
4. An HCG-rich microenvironment contributes to ovarian cancer cell differentiation into endothelioid cells in a three-dimensional culture system.
Su M; Fan C; Gao S; Shen A; Wang X; Zhang Y
Oncol Rep; 2015 Nov; 34(5):2395-402. PubMed ID: 26479853
[TBL] [Abstract][Full Text] [Related]
5. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo.
Su M; Feng YJ; Yao LQ; Cheng MJ; Xu CJ; Huang Y; Zhao YQ; Jiang H
Int J Gynecol Cancer; 2008; 18(3):476-86. PubMed ID: 17645504
[TBL] [Abstract][Full Text] [Related]
6. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.
Tang J; Wang J; Fan L; Li X; Liu N; Luo W; Wang J; Wang Y; Wang Y
Oncotarget; 2016 Apr; 7(17):24050-62. PubMed ID: 26992227
[TBL] [Abstract][Full Text] [Related]
7. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
Gawronska B; Leuschner C; Enright FM; Hansel W
Gynecol Oncol; 2002 Apr; 85(1):45-52. PubMed ID: 11925119
[TBL] [Abstract][Full Text] [Related]
8. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
9. Expression and production of human chorionic gonadotropin (hCG) in the normal secretory endometrium: evidence of CGB7 and/or CGB6 beta hCG subunit gene expression.
Zimmermann G; Ackermann W; Alexander H
Biol Reprod; 2012 Mar; 86(3):87. PubMed ID: 21832169
[TBL] [Abstract][Full Text] [Related]
10. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
11. Relationship between CD177 and the vasculogenic mimicry, clinicopathological parameters, and prognosis of epithelial ovarian cancer.
Jiang J; Chen Y; Zhang M; Zhou H; Wu H
Ann Palliat Med; 2020 Nov; 9(6):3985-3992. PubMed ID: 33302660
[TBL] [Abstract][Full Text] [Related]
12. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
[TBL] [Abstract][Full Text] [Related]
13. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer.
Parrott JA; Doraiswamy V; Kim G; Mosher R; Skinner MK
Mol Cell Endocrinol; 2001 Feb; 172(1-2):213-22. PubMed ID: 11165055
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Vasculogenic Mimicry in Breast Cancer.
Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J
Front Oncol; 2020; 10():220. PubMed ID: 32175277
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
[TBL] [Abstract][Full Text] [Related]
17. Vasculogenic mimicry is a major feature and novel predictor of poor prognosis in patients with orbital rhabdomyosarcoma.
Chen L; He Y; Sun S; Sun B; Tang X
Oncol Lett; 2015 Sep; 10(3):1635-1641. PubMed ID: 26622724
[TBL] [Abstract][Full Text] [Related]
18. Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1.
Li B; Mao X; Wang H; Su G; Mo C; Cao K; Qiu S
Oncol Lett; 2018 Apr; 15(4):5193-5200. PubMed ID: 29552157
[TBL] [Abstract][Full Text] [Related]
19. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
